Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 10Pain, Postoperative 9Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Lung Neoplasms 8Stomach Neoplasms 6Colonic Neoplasms 6Brain Neoplasms 6Thyroid Neoplasms 5Prostatic Neoplasms 5Colorectal Neoplasms 5Agnosia 4Thromboembolism 3Pain 3Ovarian Neoplasms 3Myofibroma 3Head and Neck Neoplasms 3Depression 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Neoplasm Metastasis 2Leiomyoma 2Hemangioma 2Arthritis, Rheumatoid 2Vomiting 1Visceral Pain 1Uterine Cervical Neoplasms 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 4pimonidazole 2TH 302 2gadobutrol 1fluoromisonidazole 1Surgical Procedures, Operative 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Radiotherapy 1Propofol 1Positron Emission Tomography Computed Tomography 1Pancreaticoduodenectomy 1Oxygen 1NVP-BKM120 1Ketamine 1Gemcitabine 1Ferrosoferric Oxide 1Dexmedetomidine 1Blood Specimen Collection 1Biopsy 1Bacterial Load 1Atovaquone 13-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypoxia × Saline Solution × Clear all
NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Aristotle University Of Thessaloniki

Phase 4 Completed
56 enrolled
CNS

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡